ABLENIO

We are a publicly traded biotechnology company developing novel therapies for orphan and non-orphan diseases with a specific focus on blocking certain parts of the immune system involved in the disease process. With our unique portfolio of neutralizing monoclonal antibodies, Ablenio is targeting chronic diseases with large market potential and unmet medical need... Ablenio Biosciences LLC. is a publicly traded biotechnology company that has developed cutting-edge highly selective therapeutics for complement-mediated diseases.

Also known as: Ablenio Biosciences, Ablenio Biosciences LLC

Primary location: Cleveland United States